Dr Samantha Walker, Director of Research and Innovation at Asthma + Lung UK, the leading lung charity, discusses the socioeconomic costs of lung conditions and the need for great lung health research.
Decades after the ban on asbestos, we still struggle with the impact of mesothelioma – is it possible to eliminate this devastating cancer? We put the question to UK charity Asthma + Lung UK.
Asthma is a chronic inflammatory disease that is characterized by bronchial hyperreactivity (wheezing due to narrowing of the airways) and it disproportionately affects African Americans.
Dr Erika Kennington, Head of Research and Innovation at Asthma + Lung UK, says that millions of women are drawing the short straw with too little research exploring the effect of female sex hormones on asthma.
Sarah MacFadyen, Vice Chair of the Taskforce for Lung Health and Head of Policy and External Affairs at Asthma UK and the British Lung Foundation, says it’s time that tobacco dependency was treated just like any other illness.
Zak Bond, Policy Officer at the British Lung Foundation, explores why the government must commit to stronger air pollution targets to protect our lungs as we recover from COVID-19.
Michael Roth discusses soluble circulating cytokine receptors in chronic inflammatory lung diseases, which he describes as the under-estimated regulators of inflammation and remodelling.
According to Maximilian Kunisch and Giuseppe De Carlo from the European Federation of Allergies and Airways Diseases Patients' Associations, respiratory patients in Europe need to set the research priorities for asthma and chronic obstructive pulmonary disease (COPD).
